Clinical trials
Withdrawn Phase 2 Glioblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| NYU Langone Health | 3 |
| Duke University | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| Constantinos Hadjipanayis | 1 |
| Dana-Farber Cancer Institute | 1 |
| GenSpera, Inc. | 1 |
| John M. Buatti | 1 |
| Lisata Therapeutics, Inc. | 1 |
| Maastricht Radiation Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 26 |
| Glioma | 7 |
| Gliosarcoma | 6 |
| Brain Neoplasms | 5 |
| Oligodendroglioma | 5 |
| Astrocytoma | 4 |
| Central Nervous System Neoplasms | 4 |
| Ependymoma | 2 |
| Recurrence | 2 |
| Glioma, Subependymal | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.